Riebman Jerome 4
4 · AZIYO BIOLOGICS, INC. · Filed Oct 8, 2020
Insider Transaction Report
Form 4
Riebman Jerome
Chief Medical Officer
Transactions
- Award
Stock Option (Right to Buy)
2020-10-07+30,412→ 30,412 totalExercise: $17.00Exp: 2030-10-06→ Class A Common Stock (30,412 underlying) - Award
Restricted Stock Units
2020-10-07+10,186→ 10,186 total→ Class A Common Stock (10,186 underlying)
Footnotes (3)
- [F1]This option vests and becomes exercisable in 4 substantially equal annual installments on each of the successive years following October 7, 2020.
- [F2]Each restricted stock unit represents a contingent right to receive one share of Issuer Class A common stock.
- [F3]The restricted stock units will vest in full on October 7, 2023 and do not have an expiration date.